Condition
Vasovagal Syncope (VVS)
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting2
Enrolling By Invitation1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07459478Not ApplicableRecruitingPrimary
Assesment of the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial
NCT07030218Enrolling By InvitationPrimary
A Warning Red Flag Classification System to Predict Risk of Vasovagal Syncope During Office Hysteroscopy
NCT02558972Phase 2Terminated
Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)
NCT05755737Phase 2RecruitingPrimary
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
Showing all 4 trials